Skip to main content

Table 3 Estimated differences in diagnostic interval (DI) (calendar days) during and after the implementation of CPPs compared to before the implementation (Model 1), and also according to referral route after the implementation: to a CPP (after-CPP) or not (after-no CPP) (Model 2) (N=11,640)

From: Diagnostic intervals before and after implementation of cancer patient pathways – a GP survey and registry based comparison of three cohorts of cancer patients

 

Model 11

Model 21after-group split by referral to a CPP or not

During vs. before

After vs. before

After-CPP vs. before

After-no CPP vs. before

After-CPP vs. during

After-no CPP vs. during

 

Estimate (95% CI)

Estimate (95% CI)

Estimate (95% CI)

Estimate (95% CI)

Estimate (95% CI)

Estimate (95% CI)

Percentile

      

25th

−7 (−8;-5)

−10 (−11;-8)

−12 (−13;-11)

−6 (−8;-5)

−8 (−9;-7)

0 (−2;1)

50th

−14 (−16;-11)

−17 (−19;-15)

−23 (−25;-21)

−9 (−12;-7)

−15 (−17;-12)

4 (1;7)

75th

−22 (−27;-16)

−27 (−34;-20)

−46 (−51;-41)

−11 (−21;-1)

−32 (−37;-28)

10 (1;19)

90th

−53 (−76;-30)

−44 (−65;-23)

−110 (−153;-67)

−6 (−77;66)

−80 (−126;-34)

48 (−49;145)

  1. Estimates with 95% confidence intervals (95%CI) are displayed for the 25th, the 50th, the 75th percentile and the 90th percentiles. Bold estimates indicate statistical significance at p = 0.05 level or less.
  2. Model 1 reference: before implementation group, cohort, female, 45 years of age, cancer sites, no co-morbidity, high disposable income and high educational level.
  3. Model 2 = model 1, but with ‘after group’ split by referral route (CPP).
  4. 1Adjusted for gender, age, cancer site, co-morbidity, educational level and disposable income.